Collectively, this data support a positive and strong correlation between MTA1 and HIF‐1α expression suggesting potential benefits of MTA1‐targeting antiangiogenic therapeutic strategies, particularly for advanced PCa. The gene discussed is MTA1; the disease is posterior cortical atrophy.